The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages

Bibliography

• Hall SS. A Commotion in the Blood. Henry Holt and Co.; NewYork: 1998
   Google Scholar
• Pawelek JM, Low KB, Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol 2003;4:548-56
   PubMed Web of Science ®Google Scholar
• Coley WB. Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and Bacillus prodigiosus. Am J Med Sci 1906;131:375-430
   Google Scholar
• Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 1893;105:487-511
   Google Scholar
• Coley-Nauths H, Fowler GA, Bogatko FH. A review of the influence of bacterial infection and bacterial products (Coley's toxins) on malignant tumours in man. Acta Med Scand 1953;145:5-97
   Google Scholar
• Coley WB. Further observations upon the treatment of malignant tumors with the toxins of erysipelas and Bacillus prodigiosus with a report of 160 cases. Johns Hopkins Hosp Bull 1896;7:175
   Google Scholar
• Thotathil Z, Jameson MB. Early experience with novel immunomodulators for cancer treatment. Expert Opin Investig Drugs 2007;16:1391-403
   PubMed Web of Science ®Google Scholar
• Fehleisen F. Die etiologie des erysipelas. Theodor Fischer; Berlin: 1883
   Google Scholar
• Malmgren RA, Flanigan CC. Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res 1955;15:473-8
   PubMed Web of Science ®Google Scholar
• Gericke D, Engelbart K. Oncolysis by Clostridia. II. Experiments on a tumor spectrum with a variety of Clostridia in combination with heavy metal. Cancer Res 1964;24:217-21
   PubMed Web of Science ®Google Scholar
• Moese JR, Moese G. Oncolysis by Clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic Clostridia against the Ehrlich carcinoma. Cancer Res 1964;24:212-16
   PubMed Web of Science ®Google Scholar
• Thiele EH, Arison RN, Boxer GE. Oncolysis by Clostridia. III. Effects of Clostridia and chemotherapeutic agents on rodent tumors. Cancer Res 1964;24:222-33
   PubMed Web of Science ®Google Scholar
• Kohwi Y, Imai K, Tamura Z, Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice. Gann 1978;69:613-18
   PubMedGoogle Scholar
• Kimura NT, Taniguchi S, Aoki K, Baba T. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res 1980;40:2061-8
   PubMed Web of Science ®Google Scholar
• Fox ME, Lemmon MJ, Mauchline ML, Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered Clostridia. Gene Ther 1996;3:173-8
   PubMed Web of Science ®Google Scholar
• Lemmon MJ, Van Zijl P, Fox ME, Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther 1997;4:791-6
   PubMed Web of Science ®Google Scholar
• Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-16
   PubMed Web of Science ®Google Scholar
• Low KB, Ittensohn M, Le T, Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol 1999;17:37-41
   PubMed Web of Science ®Google Scholar
• Clairmont C, Lee KC, Pike J, Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 2000;181:1996-2002
   PubMed Web of Science ®Google Scholar
• Sznol M, Lin SL, Bermudes D, Use of preferentially replicating bacteria for the treatment of cancer. J Clin Invest 2000;105:1027-30
   PubMed Web of Science ®Google Scholar
• Yazawa K, Fujimori M, Amano J, Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther 2000;7:269-74
   PubMed Web of Science ®Google Scholar
• Yazawa K, Fujimori M, Nakamura T, Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat 2001;66:165-70
   PubMed Web of Science ®Google Scholar
• Forbes NS, Munn LL, Fukumura D, Jain RK. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 2003;63:5188-93
   PubMed Web of Science ®Google Scholar
• Dang LH, Bettegowda C, Huso DL, Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 2001;98:15155-60
   PubMed Web of Science ®Google Scholar
• Kasinskas RW, Forbes NS. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol Bioeng 2006;94:710-21
   PubMed Web of Science ®Google Scholar
• Kasinskas RW, Forbes NS. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res 2007;67:3201-9
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Fujimori M, Sasaki T, Targeting solid tumors with non-pathogenic obligate anaerobic bacteria. Cancer Sci 2010;101:1925-32
   PubMed Web of Science ®Google Scholar
• Stritzker J, Weibel S, Seubert C, Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int J Med Microbiol 2010;300:449-56
   PubMed Web of Science ®Google Scholar
• Crull K, Bumann D, Weiss S. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol 2011;62:75-83
   PubMed Web of Science ®Google Scholar
• Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 2010;10:785-94
   PubMed Web of Science ®Google Scholar
• Galmbacher K, Heisig M, Hotz C, Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression. PLoS One 2010;5(3):e9572
   PubMed Web of Science ®Google Scholar
• Yu YA, Timiryasova T, Zhang Q, Optical imaging: bacteria, viruses, and mammalian cells encoding light emitting proteins reveal the locations of primary tumors and metastases in animals. Anal Bioanal Chem 2003;377:964-72
   PubMed Web of Science ®Google Scholar
• Yu YA, Shabahang S, Timiryasova TM, Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004;22:313-20
   PubMed Web of Science ®Google Scholar
• Newell KA, Ellenhorn JD, Bruce DS, Bluestone JA. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci USA 1991;88:1074-8
   PubMed Web of Science ®Google Scholar
• Li X, Fu G-F, Fan Y-R, Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther 2003;10:105-11
   PubMed Web of Science ®Google Scholar
• Parker RC, Plummer HC, Siebenmann CO, Chapman MG. Effect of histolyticus infection and toxin on transplantable mouse tumors. Proc Soc Exp Biol Med 1947;66:461-7
   PubMed Web of Science ®Google Scholar
• Engelbart K, Gericke D. Oncolysis by Clostridia. V. Transplanted tumors of the hamster. Cancer Res 1964;24:239-43
   PubMed Web of Science ®Google Scholar
• Weibel S, Stritzker J, Eck M, Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 2008;10:1235-48
   PubMed Web of Science ®Google Scholar
• Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-9
   PubMed Web of Science ®Google Scholar
• Pawelek JM, Low KB, Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 1997;57:4537-44
   PubMed Web of Science ®Google Scholar
• Toso JF, Gill VJ, Hwu P, Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002;20:142-52
   PubMed Web of Science ®Google Scholar
• Mengesha A, Dubois L, Lambin P, Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella. Cancer Biol Ther 2006;5:1120-8
   PubMed Web of Science ®Google Scholar
• Arrach N, Zhao M, Porwollik S, Salmonella promoters preferentially activated inside tumors. Cancer Res 2008;68:4827-32
   Google Scholar
• Zhao M, Yang M, Li XM, Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005;102:755-60
   PubMed Web of Science ®Google Scholar
• Zhao M, Yang M, Ma H, Targeted therapy with a Salmonella typhimurium leucine arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006;66:7647-52
   PubMed Web of Science ®Google Scholar
• Zhao M, Geller J, Ma H, Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007;104:10170-4
   PubMed Web of Science ®Google Scholar
• Nagakura C, Hayashi K, Zhao M, Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009;29:1873-8
   PubMed Web of Science ®Google Scholar
• Yam C, Zhao M, Hayashi K, Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 2010;164:248-55
   Google Scholar
• Kimura H, Zhang L, Zhao M, Targeted therapy of spinal cord glioma with a genetically-modified Salmonella typhimurium. Cell Prolif 2010;43:41-8
   PubMed Web of Science ®Google Scholar
• Hayashi K, Zhao M, Yamauchi K, Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009;106:992-8
   PubMed Web of Science ®Google Scholar
• Hayashi K, Zhao M, Yamauchi K, Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 2009;8:870-5
   PubMed Web of Science ®Google Scholar
• Leschner S, Westphal K, Dietrich N, Tumor invasion of Salmonella enteric serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One 2009;4:e6692
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang L, Hoffman RM, Zhao M. Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 2010;9:4518-24
   PubMed Web of Science ®Google Scholar
• Arrach N, Cheng P, Zhao M, High-throughput screening for Salmonella avirulent mutants that retain targeting of solid tumors. Cancer Res 2010;70:2165-70
   Google Scholar
• Nguyen VH, Kim HS, Ha JM, Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 2010;70:18-23
   PubMed Web of Science ®Google Scholar
• Hoffman RM. Tumor-seeking Salmonella amino acid auxotrophs. Curr Opin Biotechnol 2011;22:917-23
   PubMed Web of Science ®Google Scholar
• Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 1984;738:49-87
   PubMed Web of Science ®Google Scholar